NCT03787524

Brief Summary

In order to discover dysphagia scales, which shows meaningful predictability of aspiration and functional health status in patients with acute stroke, authors plan to find out more predictable indicators than existing penetration-aspiration scale (PAS) to validate their predictions and their internal and external validity over 6 months following stroke .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
68

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 26, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

March 4, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
Last Updated

December 17, 2019

Status Verified

December 1, 2019

Enrollment Period

1.9 years

First QC Date

December 21, 2018

Last Update Submit

December 15, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of Body mass index (Kg/m2)

    Body mass index (Kg/m2)

    1 day before and 1 day, 3 weeks after the VFSS, 3 month, 6 months and 9 months after the stroke onset

Secondary Outcomes (1)

  • Check the Penetration/aspiration on PAS

    1 day after the VFSS, 3 month, 6 months and 9 months after the stroke onset

Other Outcomes (11)

  • Change of Grasping force (kg)

    1 day before and 1 day, 3 weeks after the VFSS, 3 month, 6 months and 9 months after the stroke onset

  • Change of Korean-modified Barthel index

    1 day before and 1 day, 3 weeks after the VFSS, 3 month, 6 months and 9 months after the stroke onset

  • Change of Swallowing-Quality of Life

    1 day before and 1 day, 3 weeks after the VFSS, 3 month, 6 months and 9 months after the stroke onset

  • +8 more other outcomes

Study Arms (2)

Dysphagia group

Acute stroke patients who will be diagnosed dysphagia according to VFSS results.

No dysphagia group

Acute stroke patient who showed no dysphagia according to VFSS results.

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Based on the raw data of BMI by Batsis et al's report in 2017 (mean value of two groups: 28.5 and 27.6, mean SD of two groups: 1.0), authors calculated total numbers of subjects, based on the Kang method using G power 3.1. Assuming the between factors analysis using the F-test of MANOVA, effect size 0.45, α value ≤0.05, power 0.8, number of groups 2, and number of repeated measures 4 were inputted. Supposed that the dropout rate was 20%, 34 patients in each group were finally calculated.

You may qualify if:

  • brain MRI / CT-based stroke patients who were referred for VFSS

You may not qualify if:

  • In case of a history of dysphagia
  • Unstable patient in neurology
  • or higher of NIHSS 1a (level of consciousness)
  • Patients with other neurological diseases
  • Patients with decompression skull resection
  • Refusal of participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ulsan University Hospital

Ulsan, 682-714, South Korea

RECRUITING

MeSH Terms

Conditions

StrokeDeglutition Disorders

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Chang Ho Hwang, M.D., Ph.D.

    Ulsan University Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 21, 2018

First Posted

December 26, 2018

Study Start

March 4, 2019

Primary Completion

January 31, 2021

Study Completion

January 31, 2021

Last Updated

December 17, 2019

Record last verified: 2019-12

Locations